SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Farooq AV, Gibbons AG, Council MD, Harocopos GJ, Holland S, Judelson J, Shoss BL, Schmidt EJ, Md Noh UK, D'Angelo A, Chundury RV, Judelson R, Perez VL, Huang AJ. Am. J. Ophthalmol. 2016; 174: 119-125.

Affiliation

Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, USA. Electronic address: huanga@vision.wustl.edu.

Copyright

(Copyright © 2016, Elsevier Publishing)

DOI

10.1016/j.ajo.2016.10.007

PMID

27793603

Abstract

PURPOSE: To report a series of patients who developed corneal toxicity after exposure to aquarium coral palytoxin.

DESIGN: Multi-center retrospective case series.

METHODS: Retrospective review.

RESULTS: Seven patients presented with corneal findings ranging from superficial punctate epitheliopathy to bilateral corneal melt with subsequent perforation. Among those with mild corneal findings, resolution was achieved with topical steroids and lubrication, whereas some patients who developed progressive corneal melt required therapeutic penetrating keratoplasty. The history in all patients revealed exposure to aquarium zoanthid corals shortly prior to disease onset. A review of the literature revealed that there are few prior reports of coral-associated corneal toxicity and that some species of coral secrete a substance known as palytoxin, a potent vasoconstrictor that inhibits the membranous sodium-potassium ATPase pump across cell types and can cause rapid death if inhaled or ingested.

CONCLUSIONS: This is the largest case series to date demonstrating patients with aquarium coral palytoxin-associated corneal toxicity, and is the first to provide details of related histopathologic findings. Similar to other forms of toxic keratoconjunctivitis, a detailed history and careful clinical assessment are required, as well as timely removal of the offending agent from the patients' ocular milieu and environment. Mild ocular surface and corneal disease may be treated effectively with aggressive topical steroid therapy and lubrication. Given the potential severity of ocular as well as systemic adverse effects, there should be increased awareness of this entity among eye care professionals, aquarium enthusiasts and the general public.

Copyright © 2016. Published by Elsevier Inc.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print